$NVIDIA (NVDA.US)$'s stock fell by 7% to $103.73, significantly outpacing the $Nasdaq Composite Index (.IXIC.US)$'s 1.3% decline, marking its lowest closing share price since May 23. The stock is now down 26% from its June peak of over $140 per share.
Apple to Train AI Models with Google Chips Instead of Nvidia
Apple announced that its AI models, part of its Apple Intelligence system, were pretrained using Google's Tensor P...

$Hims & Hers Health (HIMS.US)$ has added GLP-1 weight-loss injections to its portfolio of products.
The injections will have the same active ingredient as $Novo-Nordisk A/S (NVO.US)$ ’s Ozempic and Wegovy.
HIMS stock is up by nearly 100% year-to-date.
Hims & Hers added that it would provide branded GLP-1 injections once supply catches up with demand. In the upcoming months, Hims & Hers will work towards providing access to compounded tirzepatide, whic...

Updated on May 23
$NVIDIA (NVDA.US)$'s stock has experienced a meteoric rise this year, nearly doubling in value—a performance that may reflect market anticipation of the company's forthcoming earnings report.
As a key player in the AI sector, NVIDIA's movements are closely watched and have a significant influence on market trends. With recent U.S. market highs, investors are keen to see if the momentum can be sustained.
The eagerly awaited Q1 fin...